Gary Sender is a seasoned executive with extensive experience in the biotechnology and pharmaceutical industries. Currently, Gary serves as a Board Member for multiple companies, including Apnimed, iBio, Inc., Harmony Biosciences, Schrödinger, and Gennao Bio, where responsibilities include chairing and participating in various audit and compensation committees. Previous roles include Chief Financial Officer at Nabriva Therapeutics plc and Synergy Pharmaceuticals, as well as Senior Vice President of Finance at Shire Pharmaceuticals. Gary’s educational background includes an MBA in Finance from Carnegie Mellon University and a Bachelor's Degree in Finance from the Questrom School of Business at Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices